In 2022, Medcan became the first wellness provider in the country to enter the age of truly personalized medicine by providing whole genome sequencing to clients seeking the most advanced technology available to promote longevity. Now, a year later, who is getting their whole genome sequenced, and what impact has the decision had on their lives? What are some of the most surprising findings? Director of clinical innovation Allison Hazell (pictured above) leads director of genetics Jessica Gu and genetic counsellor Justin Lorentz in a fascinating discussion that also features CMO Dr. Peter Nord reflecting on his own experience getting his whole genome sequenced.